Peritoneal metastasis (PM) is commonly observed in patients with colorectal cancer (CRC). The outcome of these patients is poor, with an average survival of only six months without therapy, which requires a better understanding of PM biology and new treatment strategies
Colorectal cancer is the third leading cause of cancer-related death in males and females in develop...
Selected patients with colorectal cancer peritoneal metastasis (CRPM) and extraperitoneal disease co...
Objectives: In our study, we aimed to (1) create a peritoneal metastasis (PM) model in nude mice, ad...
The presence of peritoneal metastases (PM) in patients with colorectal cancer (CRC) is associated wi...
Peritoneal metastasis (PM) occurs in approximately one in four colorectal cancer (CRC) patients. The...
Colorectal peritoneal metastases (CPM) are associated with abbreviated survival and significantly im...
The presence of peritoneal metastases in patients with advanced colorectal cancer is associated with...
Peritoneal metastasis (PM) originating from gastrointestinal cancer was considered a terminal diseas...
Peritoneum is one of the common sites of metastasis in advanced stage colorectal cancer patients. Co...
Background: Patients with peritoneal metastases from colorectal cancer have a poor prognosis. If the...
PURPOSE: Colorectal cancer (CRC) patients with peritoneal metastases (CRPM) have limited treatment o...
International audienceCarcinoma of the colon and rectum known as colorectal cancer (CRC) is a common...
This thesis focuses on patients with peritoneal metastases of colorectal cancer. Part 1 shows that t...
Peritoneal metastases (PM) from colorectal cancer (CRC) were traditionally associated with bad progn...
Colorectal cancer (CRC) patients with peritoneal metastases (PM) are currently treated with cytoredu...
Colorectal cancer is the third leading cause of cancer-related death in males and females in develop...
Selected patients with colorectal cancer peritoneal metastasis (CRPM) and extraperitoneal disease co...
Objectives: In our study, we aimed to (1) create a peritoneal metastasis (PM) model in nude mice, ad...
The presence of peritoneal metastases (PM) in patients with colorectal cancer (CRC) is associated wi...
Peritoneal metastasis (PM) occurs in approximately one in four colorectal cancer (CRC) patients. The...
Colorectal peritoneal metastases (CPM) are associated with abbreviated survival and significantly im...
The presence of peritoneal metastases in patients with advanced colorectal cancer is associated with...
Peritoneal metastasis (PM) originating from gastrointestinal cancer was considered a terminal diseas...
Peritoneum is one of the common sites of metastasis in advanced stage colorectal cancer patients. Co...
Background: Patients with peritoneal metastases from colorectal cancer have a poor prognosis. If the...
PURPOSE: Colorectal cancer (CRC) patients with peritoneal metastases (CRPM) have limited treatment o...
International audienceCarcinoma of the colon and rectum known as colorectal cancer (CRC) is a common...
This thesis focuses on patients with peritoneal metastases of colorectal cancer. Part 1 shows that t...
Peritoneal metastases (PM) from colorectal cancer (CRC) were traditionally associated with bad progn...
Colorectal cancer (CRC) patients with peritoneal metastases (PM) are currently treated with cytoredu...
Colorectal cancer is the third leading cause of cancer-related death in males and females in develop...
Selected patients with colorectal cancer peritoneal metastasis (CRPM) and extraperitoneal disease co...
Objectives: In our study, we aimed to (1) create a peritoneal metastasis (PM) model in nude mice, ad...